Hormone Replacement Therapy - Pipeline Analysis and Market Forecasts to 2016
GlobalData estimated the global hormone therapy (HT) market to be worth $2.1 billion in 2009, indicating a Compound Annual Growth Rate (CAGR) of -6.8% between 2001 and 2009. This decline in the market is mainly attributed to poor patient compliance as a result of the serious safety concerns associated with hormones. By 2016, the market is forecast to record $2.3 billion, with a CAGR of 1.2% between 2009 and 2016. The market is restrained by factors such as the poor...
View full press release